BBNaija winner, Laycon reaches out to sickle cell patients

Advertisements

Winner of the Big Brother Naija 2020 show, Laycon, has reached out to sickle cell patients in Nigeria with financial aid.

During the BBNaija show, Laycon revealed that he has a recessive form of Sickle Cell anemia.

Since winning the 2020 edition of the show, Laycon seems to have taken it upon himself to ease the conditions of people living with sickle cell anemia.

Tohai Nigeria took to social media to thank the singer for donating to sickle cell warriors support in Nigeria, they wrote on Twitter;

Thank you @itsLaycon for donating to sickle cell warriors support in Nigeria. As an organization advocating for newborn screening for Sickle Cell disease and associated treatments for children in low resources settings in Nigeria, we appropriate your generosity. God bless you big

Another social media user @EkunBolaji revealed that the son of her cousin paid less for drugs after Laycon had dropped cash for sickle cell patients. EkunBolaji wrote;

My cousin took her son to sickle cell foundation idiaraba to get drug for her son , she was told to pay little amount of money cos Laycon gave them money to treat SS patient. She cried and she was so happy cos her president love them. Thanks Laycon

var loaded = false; var loadFB = function() { if (loaded) return; loaded = true; (function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.5"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk')); }; setTimeout(loadFB, 0); $('body').on('bimberLoadFbSdk', loadFB); })(jQuery);

Related posts

Why Waiting is Costly: Join YipeeBet’s Christmas Promo Before It’s Too Late

Step into a New Experience: YipeeBet’s Upgraded Platform Awaits You!

Play Top Games, Win Big Rewards With YipeeBet! 🏆

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More